期刊
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
卷 -, 期 17, 页码 3445-3452出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejic.200400195
关键词
antitumor agents; NMR spectroscopy; O ligands; platinum; S ligands
Cisplatin is the most important metal-based drug used in tumor therapy; however, it suffers from severe side effects and a limited spectrum of activity. Since phosphonates are known to have a selective tropism for bones and calcified tissues, we have carried on the synthesis of different platinum complexes with a phosphonate ligand. The ligand used is diethyl [(methylsulfinyl)methyl]phosphonate (SMP), which can act as an O,S-donor towards Pt. Moreover, since the sulfur atom is a stable stereogenic center, the ligand is obtained in two enantiomeric forms. The synthesised complexes have the general formula [PtL2(SMP)], in which L-2 stands for a bidentate (dimethylmalonate, 1,2-diaminocyclohexane, ethylenedi-amine) or two monodentate (chloride) ligands. The formation of a five-membered chelate ring contributes to the chemical stability of complexes with SMP, and 2D NMR experiments have allowed determination of the ring puckering, which is dependent upon the chirality of the sulfur stereocenter. For the (S) configuration at the sulfur center (free ligand), the 6 puckering of the chelate ring is favoured. Preliminary studies have shown that these compounds are stable under physiological conditions. ((C) Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据